Objective/Hypothesis: Recent work from Dr. Fink's laboratory suggests that IME4 (early inducer of meiosis gene) acts as a switch in determining whether cells will undergo meiosis or filament and produces an antisense transcript under a/alpha control. Because of the connection between IME4 and the filamentation pathway in S. cerevisiae, and since there is both an IME4 homolog and MTL a1/alpha2 binding sites in the gene regulatory regions of C. albicans' IME4, my hypothesis is that a1/alpha2 plays a role in regulating IME4 antisense and sense expression and that IME4 regulation in S. cerevisiae is conserved in C. albicans. This regulatory mechanism is likely to have potential implications in the C. albicans' pathogenically important morphological switch from yeast to filamentous growth.
Specific Aims : I. Determine the role and regulatory mechanism of IME4 in cell-fate determination in S. cerevisiae. II. Elucidate the function and mechanism of regulation of C. albicans' IME4.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32GM073338-02
Application #
7090805
Study Section
Special Emphasis Panel (ZRG1-F05 (20))
Program Officer
Portnoy, Matthew
Project Start
2005-07-01
Project End
2008-06-30
Budget Start
2006-07-01
Budget End
2007-06-30
Support Year
2
Fiscal Year
2006
Total Cost
$48,796
Indirect Cost
Name
Whitehead Institute for Biomedical Research
Department
Type
DUNS #
120989983
City
Cambridge
State
MA
Country
United States
Zip Code
02142